The results showed that high expression of CLDN1 and HCAR3 was associated with poor prognosis, whereas high expression of FNBP1L and BRCA2 was associated with good prognosis in the TCGA ESCC cohort (Figure 2). This evidence concerns the gene FNBP1L and esophageal squamous cell carcinoma.